We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Mitochondrial Toxicity in Drug Discovery

Mitochondrial Toxicity in Drug Discovery content piece image

Drug-induced mitochondrial dysfunction has been linked to compound attrition, organ toxicity, black-box warnings, and market withdrawals, therefore it is important to identify mitochondrial toxicity during the early stages of the drug discovery process.

New in vitro strategies are being introduced to the market, which are more specific and sensitive.

Download this infographic to learn about:

  • The impact of mitochondrial toxicity in drug discovery
  • The benefits of novel in vitro strategies for drug safety
  • New in vitro products on the market